VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.
Röhrig F, Vorlová S, Hoffmann H, Wartenberg M, Escorcia FE, Keller S, Tenspolde M, Weigand I, Gätzner S, Manova K, Penack O, Scheinberg DA, Rosenwald A, Ergün S, Granot Z, Henke E.
Röhrig F, et al. Among authors: granot z.
Oncogene. 2017 Jan 5;36(1):1-12. doi: 10.1038/onc.2016.182. Epub 2016 Jun 6.
Oncogene. 2017.
PMID: 27270432
Free PMC article.